Cargando…

Editorial: Exploring Cancer Metabolic Reprogramming through Molecular Imaging

Detalles Bibliográficos
Autores principales:	Podo, Franca, Bhujwalla, Zaver M., Iorio, Egidio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5405072/ https://www.ncbi.nlm.nih.gov/pubmed/28491821 http://dx.doi.org/10.3389/fonc.2017.00079

Ejemplares similares

Choline Metabolism Alteration: A Focus on Ovarian Cancer
por: Bagnoli, Marina, et al.
Publicado: (2016)

Key Players in Choline Metabolic Reprograming in Triple-Negative Breast Cancer
por: Iorio, Egidio, et al.
Publicado: (2016)

Effect of Pantethine on Ovarian Tumor Progression and Choline Metabolism
por: Penet, Marie-France, et al.
Publicado: (2016)

Challenges and Initiatives in Diversity, Equity and Inclusion in Cancer Molecular Imaging
por: Daldrup-Link, Heike E., et al.
Publicado: (2021)

Targeting Phospholipid Metabolism in Cancer
por: Cheng, Menglin, et al.
Publicado: (2016)

Water and Collagen Content Are High in Pancreatic Cancer: Implications for Quantitative Metabolic Imaging
por: Penet, Marie-France, et al.
Publicado: (2021)

In vivo Magnetic Resonance Metabolic and Morphofunctional Fingerprints in Experimental Models of Human Ovarian Cancer
por: Canese, Rossella, et al.
Publicado: (2016)

Global metabolic profile identifies choline kinase alpha as a key regulator of glutathione-dependent antioxidant cell defense in ovarian carcinoma
por: Granata, Anna, et al.
Publicado: (2015)

Biomimetic Nanoparticles Camouflaged in Cancer Cell Membranes and Their Applications in Cancer Theranostics
por: Jin, Jiefu, et al.
Publicado: (2020)

The Tumor Microenvironment Modulates Choline and Lipid Metabolism
por: Mori, Noriko, et al.
Publicado: (2016)

Editorial: Metabolic reprogramming in breast cancer
por: Scatena, Cristian, et al.
Publicado: (2022)

Activation of Phosphatidylcholine-Specific Phospholipase C in Breast and Ovarian Cancer: Impact on MRS-Detected Choline Metabolic Profile and Perspectives for Targeted Therapy
por: Podo, Franca, et al.
Publicado: (2016)

Editorial: Cell Stress, Metabolic Reprogramming, and Cancer
por: Giannattasio, Sergio, et al.
Publicado: (2018)

Editorial: Hallmark of cancer: Reprogramming of cellular metabolism
por: Kaur, Baljinder, et al.
Publicado: (2023)

Functional roles of FAP-α in metabolism, migration and invasion of human cancer cells
por: Mori, Noriko, et al.
Publicado: (2023)

Molecular Imaging of Metabolic Reprograming in Mutant IDH Cells
por: Viswanath, Pavithra, et al.
Publicado: (2016)

Will magnetic resonance imaging (MRI)-based contrast agents for molecular receptor imaging make their way into the clinic?
por: Glunde, Kristine, et al.
Publicado: (2008)

Reprogramming of VEGF-mediated extracellular matrix changes through autocrine signaling
por: Goggins, Eibhlin, et al.
Publicado: (2023)

Molecular Effects of Doxorubicin on Choline Metabolism in Breast Cancer()()
por: Cheng, Menglin, et al.
Publicado: (2017)

Editorial: Metabolic reprogramming for acquiring therapeutic resistance in glioblastoma
por: Hsu, Tsung-I
Publicado: (2023)

Ascites Volumes and the Ovarian Cancer Microenvironment
por: Penet, Marie-France, et al.
Publicado: (2018)

Characterization of lipomatous tumors with high-resolution (1)H MRS at 17.6T: Do benign lipomas, atypical lipomatous tumors and liposarcomas have a distinct metabolic signature?
por: Bharti, Santosh Kumar, et al.
Publicado: (2022)

Editorial: Proteomic and metabolic reprogramming in myeloma cells within the tumor microenvironment
por: Milan, Enrico, et al.
Publicado: (2023)

Editorial: Therapy resistance in tumor microenvironment: metabolic reprogramming and purinergic signaling
por: Zanoni, Michele, et al.
Publicado: (2023)

PD-L1 siRNA Theranostics With a Dextran Nanoparticle Highlights the Importance of Nanoparticle Delivery for Effective Tumor PD-L1 Downregulation
por: Pacheco-Torres, Jesus, et al.
Publicado: (2021)

Editorial: Cancer cell reprogramming: Impact on carcinogenesis and cancer progression
por: Zhao, Yue, et al.
Publicado: (2023)

Molecular and Metabolic Reprogramming: Pulling the Strings Toward Tumor Metastasis
por: Hipólito, Ana, et al.
Publicado: (2021)

Editorial: Optical Molecular Imaging in Cancer Research
por: Zhang, Guanglei, et al.
Publicado: (2022)

Editorial: Cancer Metabolism: Molecular Targeting and Implications for Therapy
por: Ganapathy-Kanniappan, Shanmugasundaram
Publicado: (2017)

Metabolic Reprogramming in Triple-Negative Breast Cancer
por: Sun, Xiangyu, et al.
Publicado: (2020)

Lipid metabolism reprogramming in head and neck cancer
por: Liang, Jinfeng, et al.
Publicado: (2023)

Editorial: Oncogenic RAS-Dependent Reprogramming of Cellular Plasticity
por: Konstantinidou, Georgia, et al.
Publicado: (2020)

Metabolic Reprogramming in Thyroid Carcinoma
por: Coelho, Raquel Guimaraes, et al.
Publicado: (2018)

Influence of the Tumor Microenvironment on Cancer Cells Metabolic Reprogramming
por: Gouirand, Victoire, et al.
Publicado: (2018)

Metabolic Reprogramming in Gastric Cancer: Trojan Horse Effect
por: Bin, Yu-Ling, et al.
Publicado: (2022)

Metabolic Reprogramming of Thyroid Cancer Cells and Crosstalk in Their Microenvironment
por: Bao, Lisha, et al.
Publicado: (2021)

Metabolic Reprogramming in Adipose Tissue During Cancer Cachexia
por: Weber, Bahar Zehra Camurdanoglu, et al.
Publicado: (2022)

Editorial: Exploring the Potential of PSMA-PET Imaging on Personalized Prostate Cancer Treatment
por: Ilhan, Harun, et al.
Publicado: (2022)

Editorial: Cancer metabolism: molecular insights, metabolic crosstalk in the tumor microenvironment, and implications for therapy
por: Chaube, Balkrishna, et al.
Publicado: (2023)

Elucidating the Reprograming of Colorectal Cancer Metabolism Using Genome-Scale Metabolic Modeling
por: Zhang, Cheng, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_f0thkll37gjbrgjrv9e50gd38c